JP Morgan Chase
IRMD icon

JP Morgan Chase’s iRadimed IRMD Stock Holding History

JP Morgan Chase’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Buy
29,617
+17,173
+138% +$1.72M ﹤0.01% 3834
2025
Q4 		$1.21M Sell
12,444
-11,280
-48% -$968K ﹤0.01% 4475
2025
Q3 		$1.69M Sell
23,724
-1,229
-5% -$81.9K ﹤0.01% 4205
2025
Q2 		$1.49M Sell
24,953
-8,029
-24% -$440K ﹤0.01% 4125
2025
Q1 		$1.73M Sell
32,982
-13,501
-29% -$759K ﹤0.01% 3982
2024
Q4 		$2.56M Buy
46,483
+17,257
+59% +$908K ﹤0.01% 3962
2024
Q3 		$1.47M Buy
29,226
+12,051
+70% +$556K ﹤0.01% 4233
2024
Q2 		$755K Sell
17,175
-14,062
-45% -$598K ﹤0.01% 4448
2024
Q1 		$1.37M Buy
31,237
+12,524
+67% +$554K ﹤0.01% 4116
2023
Q4 		$888K Sell
18,713
-1,101
-6% -$46.3K ﹤0.01% 4410
2023
Q3 		$879K Buy
19,814
+5,267
+36% +$245K ﹤0.01% 4135
2023
Q2 		$694K Buy
14,547
+5,686
+64% +$256K ﹤0.01% 4294
2023
Q1 		$349K Buy
8,861
+4,783
+117% +$174K ﹤0.01% 4718
2022
Q4 		$115K Buy
4,078
+157
+4% +$4.49K ﹤0.01% 5301
2022
Q3 		$118K Buy
3,921
+79
+2% +$2.75K ﹤0.01% 5213
2022
Q2 		$130K Sell
3,842
-6,706
-64% -$240K ﹤0.01% 5290
2022
Q1 		$472K Sell
10,548
-6,228
-37% -$288K ﹤0.01% 4745
2021
Q4 		$774K Buy
16,776
+7,417
+79% +$299K ﹤0.01% 4562
2021
Q3 		$315K Sell
9,359
-5,191
-36% -$177K ﹤0.01% 4992
2021
Q2 		$428K Sell
14,550
-9,037
-38% -$249K ﹤0.01% 4788
2021
Q1 		$608K Sell
23,587
-1,944
-8% -$46.4K ﹤0.01% 4560
2020
Q4 		$582K Buy
25,531
+9,391
+58% +$217K ﹤0.01% 4281
2020
Q3 		$341K Sell
16,140
-1,302
-7% -$29.2K ﹤0.01% 4148
2020
Q2 		$405K Sell
17,442
-15,956
-48% -$343K ﹤0.01% 3939
2020
Q1 		$713K Sell
33,398
-13,445
-29% -$320K ﹤0.01% 3628
2019
Q4 		$1.09M Buy
46,843
+20,669
+79% +$483K ﹤0.01% 3781
2019
Q3 		$550K Buy
26,174
+9,378
+56% +$191K ﹤0.01% 4131
2019
Q2 		$337K Sell
16,796
-20,326
-55% -$479K ﹤0.01% 4419
2019
Q1 		$1.04M Buy
37,122
+1,518
+4% +$39.7K ﹤0.01% 3786
2018
Q4 		$871K Buy
35,604
+34,793
+4,290% +$935K ﹤0.01% 3835
2018
Q3 		$30K Sell
811
-3,393
-81% -$91.6K ﹤0.01% 5345
2018
Q2 		$87K Sell
4,204
-403
-9% -$7.12K ﹤0.01% 4888
2018
Q1 		$65K Sell
4,607
-2,837
-38% -$40.4K ﹤0.01% 4729
2017
Q4 		$113K Buy
7,444
+7,284
+4,553% +$92.5K ﹤0.01% 4627
2017
Q3 		$2K Hold
160
– – ﹤0.01% 4876
2017
Q2 		$1K Sell
160
-3,654
-96% -$31.2K ﹤0.01% 4879
2017
Q1 		$34K Sell
3,814
-1,666
-30% -$15.4K ﹤0.01% 4618
2016
Q4 		$61K Buy
5,480
+3,371
+160% +$36.3K ﹤0.01% 4509
2016
Q3 		$36K Buy
+2,109
New +$39.1K ﹤0.01% 4091

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's IRMD Position: Q1 2026 in Review

JP Morgan Chase increased its iRadimed (IRMD) stake by 138% in Q1 2026, buying an estimated $1.72M and bringing the position to 29,617 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

JP Morgan Chase first reported a position in IRMD in Q3 2016 and has held it in 39 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • JP Morgan Chase held 29,617 shares of iRadimed worth $2.81M as of Q1 2026.
  • JP Morgan Chase bought 17,173 iRadimed shares in Q1 2026, an estimated $1.72M.
  • iRadimed made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3834 holding.
  • JP Morgan Chase first reported a position in iRadimed in Q3 2016 and has held it in 39 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.